Indena Boswellia formulation shown to alleviate IBS symptoms

c0a9d50b-0fb2-4101-93dc-21f851aa1f47articleimage.jpg

17 Jul 2017 --- A new study has shown that Casperome, the Indena Phytosome formulation of Boswellia serrate that delivers the full natural bouquet of triterpenoids, offers rapid relief to sufferers of irritable bowel syndrome (IBS). Affecting 10 to 20 percent of the adult population and often unrecognized or untreated, Irritable bowel syndrome (IBS) is a chronic, relapsing gastrointestinal disorder. 

The supplement registry study, published in the European Review for Medical and Pharmacological Sciences, enrolled 71 otherwise healthy subjects with idiopathic IBS that each decided to follow a different management strategy. Group one took Hyoscine butylbromide, administered when needed. Group two took 10mg of papaverine hydrochloride and 10mg of belladonna extract, administered when needed. Group three used a supplementation with Casperome, one tablet of 250mg per day, for four weeks. All groups were comparable in term of age and gender distribution and they presented similar clinical characteristics at inclusion. Abdominal pain, altered bowel movements, meteorism and cramps were evaluated by subjects before the inclusion and during the last week before the end of the observational period of four weeks.

All IBS symptoms investigated improved during the period with the three management strategies, but only in the Casperome-supplemented group did the number of subjects with any IBS symptoms significantly decrease, from 58 percent to 12.5 percent. In the Casperome-supplemented group, the number of subjects who needed medical attention significantly decreased to 4.1 percent. In addition, the prevalence of side effects was significantly higher in the two groups treated with the Standard Management Strategies (28 percent for group one and 26 percent for group two) compared to Casperome supplemented subjects (8.2 percent). 

This study demonstrates that Indena’s Casperome supplementation may represent a promising alternative approach to managing symptoms associated with IBS in otherwise healthy subjects.

Related Articles

Business News

BASF: “considerable” Q2 earnings growth, but Nutrition & Health sales stall

27 Jul 2017 --- BASF Group has announced that its second quarter sales rose by 12 percent to €16.3 billion (US$19.11 billion) compared with the same period in 2016. The group states that this was largely attributable to higher prices and volumes. Amid higher raw material costs, the company raised sales prices by 7 percent; this was mainly driven by higher prices in the Chemicals segment. Sales volumes increased by 3 percent. Currency effects had a positive impact on sales and, like portfolio effects, accounted for a 1 percent increase.

Regulatory News

Cargill’s erythritol dental health claim rejected by EFSA

27 Jul 2017 --- Cargill cannot prove its EU Article 14 claim submission [disease risk reduction claim] that there is a cause-and-effect relationship between sugar-free hard confectionery with at least 90 percent erythritol and the reduction of dental plaque, according to the European Food Safety Authority (EFSA).

Business News

Algatech eyes Brazil market following Anvisa approval for astaxanthin line

27 Jul 2017 --- Algatechnologies has received Brazilian Health Regulatory Agency (Anvisa) approval for its all-natural astaxanthin AstaPure to be used as a food ingredient. This approval makes Algatech the first astaxanthin supplier to start marketing its clean-label astaxanthin under the AstaPure brand in Brazil. 

Nutrition & Health News

Binge drinking among young US adults not in college increased

27 July 2017 --- Binge drinking rates are finally down among US college students aged 18 to 24, after years of increases, but they are up among those in the same age group who are not in college, according to a study in the July issue of the Journal of Studies on Alcohol and Drugs. The same study also found that alcohol-related hospitalizations and overdose deaths have increased generally among 18- to 24-year-olds.

Business News

Food and health startups get chance to impress in Innovation Challenge

27 Jul 2017 --- Innovative ingredient projects, carried out by startups that have brought something completely new and unexpected to the food and health markets, will be rewarded as part of the Startup Innovation Challenge during the next Fi Europe & Ni show from November 28 to 30 this year.

More Articles
URL : http://www.nutritioninsight.com:80/news/indena-boswellia-formulation-shown-to-alleviate-ibs-symptoms.html